Travere Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TRAVERE, and when can generic versions of TRAVERE drugs launch?
TRAVERE has one approved drug.
There is one US patent protecting TRAVERE drugs.
There are nineteen patent family members on TRAVERE drugs in fourteen countries.
Drugs and US Patents for Travere
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-001 | Feb 17, 2023 | RX | Yes | No | 9,993,461 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-001 | Feb 17, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Travere | FILSPARI | sparsentan | TABLET;ORAL | 216403-002 | Feb 17, 2023 | RX | Yes | Yes | 9,993,461 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Travere Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Lithuania | 3222277 | ⤷ Try a Trial |
China | 102421434 | ⤷ Try a Trial |
Japan | 2012522058 | ⤷ Try a Trial |
Spain | 2811342 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.